NantHealth (NHIQ) Competitors $0.0030 -0.05 (-94.00%) As of 04/30/2025 09:30 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock NHIQ vs. SRAX, GMHS, ULY, IDW, ONFO, HLGN, PMAX, FTFT, ATXG, and XYLOShould you be buying NantHealth stock or one of its competitors? The main competitors of NantHealth include SRAX (SRAX), Gamehaus (GMHS), Urgent.ly (ULY), IDW Media (IDW), Onfolio (ONFO), Heliogen (HLGN), Powell Max (PMAX), Future FinTech Group (FTFT), Addentax Group (ATXG), and Xylo Technologies (XYLO). These companies are all part of the "business services" industry. NantHealth vs. SRAX Gamehaus Urgent.ly IDW Media Onfolio Heliogen Powell Max Future FinTech Group Addentax Group Xylo Technologies SRAX (NASDAQ:SRAX) and NantHealth (NASDAQ:NHIQ) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, community ranking, profitability, valuation, media sentiment, analyst recommendations, earnings, risk and institutional ownership. Do institutionals and insiders have more ownership in SRAX or NHIQ? 8.0% of SRAX shares are owned by institutional investors. 10.2% of SRAX shares are owned by company insiders. Comparatively, 61.3% of NantHealth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community believe in SRAX or NHIQ? SRAX received 180 more outperform votes than NantHealth when rated by MarketBeat users. CompanyUnderperformOutperformSRAXOutperform Votes18065.45% Underperform Votes9534.55% NantHealthN/AN/A Does the media refer more to SRAX or NHIQ? In the previous week, SRAX's average media sentiment score of 0.00 equaled NantHealth'saverage media sentiment score. Company Overall Sentiment SRAX Neutral NantHealth Neutral Is SRAX or NHIQ more profitable? Company Net Margins Return on Equity Return on Assets SRAXN/A N/A N/A NantHealth N/A N/A N/A Which has more risk & volatility, SRAX or NHIQ? SRAX has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500. Comparatively, NantHealth has a beta of -5.01, suggesting that its stock price is 601% less volatile than the S&P 500. Which has better earnings and valuation, SRAX or NHIQ? SRAX has higher earnings, but lower revenue than NantHealth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSRAX$29.29M0.06-$31.64MN/AN/ANantHealth$67M0.00-$67.78MN/AN/A SummarySRAX beats NantHealth on 5 of the 7 factors compared between the two stocks. Get NantHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for NHIQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NHIQ vs. The Competition Export to ExcelMetricNantHealthData processing & preparation IndustryMedical SectorNASDAQ ExchangeMarket Cap$98,000.00$4.00B$5.53B$7.99BDividend YieldN/A3.84%5.11%4.23%P/E RatioN/A69.2222.6518.64Price / Sales0.00779.78401.98103.80Price / CashN/A33.7438.1834.62Price / BookN/A6.286.754.30Net Income-$67.78M$45.12M$3.22B$248.44M7 Day PerformanceN/A5.74%1.66%1.81%1 Month PerformanceN/A5.64%4.17%4.40%1 Year PerformanceN/A14.74%16.17%5.97% NantHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NHIQNantHealthN/A$0.00-94.0%N/A-99.5%$98,000.00$67M0.00340Gap DownSRAXSRAXN/A$0.22-26.7%N/A-65.8%$6.41M$29.29M0.00130Gap DownHigh Trading VolumeGMHSGamehausN/A$1.28+1.6%N/AN/A$5.80M$145.24M0.00N/AGap UpULYUrgent.ly1.6815 of 5 stars$4.63+2.0%$12.00+159.2%-23.4%$5.76M$142.91M0.50753Short Interest ↓News CoverageGap UpIDWIDW MediaN/A$0.42+27.3%N/A-19.5%$5.70M$30.84M-1.2080News CoverageONFOOnfolio0.4941 of 5 stars$1.10-0.1%N/A+94.2%$5.64M$6.59M-1.838Short Interest ↑HLGNHeliogenN/A$0.84-0.5%N/A-21.1%$5.14M$3.92M-0.045,305Upcoming EarningsGap DownPMAXPowell MaxN/A$0.32+1.2%N/AN/A$4.76M$46.62M0.00N/AGap DownFTFTFuture FinTech Group1.2229 of 5 stars$1.47+9.3%N/A-82.7%$4.47M$18.54M0.0070Positive NewsATXGAddentax Group1.6053 of 5 stars$0.66-0.3%N/A-21.1%$4.01M$4.55M-2.37130Short Interest ↓Positive NewsGap UpXYLOXylo Technologies1.1096 of 5 stars$4.72-4.7%N/A+24.2%$3.85M$57.64M0.0030News CoveragePositive News Related Companies and Tools Related Companies SRAX Alternatives GMHS Alternatives ULY Alternatives IDW Alternatives ONFO Alternatives HLGN Alternatives PMAX Alternatives FTFT Alternatives ATXG Alternatives XYLO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NHIQ) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NantHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NantHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NHIQ Stock Free NHIQ Stock Alerts